Benefits
Equivalent to whey for muscle and strength gains
A meta-analysis of 9 randomized trials in 266 resistance-training participants found no difference between soy and whey protein supplementation for strength gains (bench press, squat) or lean body mass gains. This is a finding of equivalence, not of superiority over whey. Despite acute MPS being higher with whey, long-term outcomes converge — the protein source matters less than total daily protein adequacy.
Modest LDL cholesterol reduction
The best current estimate is modest. A 2019 meta-analysis of the 46 studies FDA identified for its claim review found that soy protein at a median 25 g/day over a median 6 weeks lowered LDL cholesterol by 4.76 mg/dL, which the authors described as roughly 3 to 4 percent. A 1995 meta-analysis of 38 trials at a mean 47 g/day had reported much larger drops (total cholesterol 9.3%, LDL 12.9%, triglycerides 10.5%), but the 2006 American Heart Association science advisory cited on this page concluded that those earlier findings had not been confirmed, put the average LDL reduction at approximately 3%, and called that very small relative to the large amount of soy protein tested. The advisory also reported that the average effect of isoflavones on LDL and other lipid risk factors was nil. FDA authorized a heart health claim in 1999 for products providing at least 6.25 g soy protein per serving, 25 g/day in total. That claim remains in the Code of Federal Regulations at 21 CFR 101.82, and FDA published a proposed rule to revoke it on 31 October 2017 that has not been withdrawn.
Complete amino acid profile
Soy is one of few plant proteins with a complete essential amino acid profile (PDCAAS = 1.0, the highest score). Especially relevant for vegetarian and vegan athletes seeking adequate leucine, lysine, and methionine without combining multiple plant sources.
Plant-based alternative to dairy protein
None of the studies referenced on this page measured satiety, appetite, body weight, GLP-1 or gastric emptying, so no claim about those outcomes is made here. What soy does offer is a complete protein at a quality comparable to dairy protein, useful for people who prefer or need a plant-based option for ethical, environmental, or lactose-intolerance reasons.
Mechanism of action
mTOR/protein synthesis pathway activation
Like other complete proteins, soy provides leucine to activate mTORC1/p70S6K signaling and trigger muscle protein synthesis. Soy has slightly lower leucine content (~8%) than whey (~11%), producing a smaller acute MPS spike, but cumulative 24-hour protein synthesis equalizes when daily protein intake is adequate (~1.6-2.2 g/kg in trained athletes).
Apolipoprotein B reduction (cholesterol mechanism)
Soy protein reduces hepatic LDL-c output via decreased apolipoprotein B (apoB) secretion and increased LDL receptor expression — opposite mechanism to dietary saturated fat. Replacement of animal protein/saturated fat with soy further amplifies the LDL benefit through dietary substitution.
Isoflavone weak ER binding (in non-isolated forms)
Soy concentrate retains isoflavones (genistein, daidzein) that bind weakly to estrogen receptors (preferentially ERβ over ERα). At typical dietary intakes the activity is selective estrogen receptor modulator-like and generally does not affect male hormone profiles. No study referenced on this page measured hormone levels or menopausal symptoms, so this describes a mechanism rather than a measured result. Soy protein isolate is largely depleted of isoflavones during processing.
Clinical trials
Random-effects pooled analysis (Messina, Lynch, Dickinson, Int J Sport Nutr Exerc Metab 28(6):674-685).
9 randomized trials, 266 participants total. 5 trials compared whey vs soy protein; 4 trials compared soy vs other animal proteins (beef, milk, dairy). All paired with resistance exercise training.
No difference between soy and animal protein for strength gains (bench press χ²=0.02, p=0.90; squat χ²=0.22, p=0.64) or lean body mass gains (whey vs soy χ²=0.00, p=0.96; other proteins vs soy χ²=0.06, p=0.80). Both groups showed significant strength and LBM increases vs control. Authors concluded soy protein supplementation produces similar resistance-exercise outcomes to whey or other animal proteins.
Random-effects pooled analysis with hierarchical mixed-effects regression (Anderson, Johnstone, Cook-, N Engl J Med 333(5):276-282).
38 controlled clinical trials evaluating soy protein vs animal protein on serum lipids in humans. Mean intake 47 g/day soy protein.
Soy protein consumption decreased: total cholesterol 23.2 mg/dL (-9.3%, 95% CI 13.5-32.9), LDL-c 21.7 mg/dL (-12.9%, 95% CI 11.2-31.7), and triglycerides 13.3 mg/dL (-10.5%, 95% CI 0.3-25.7). HDL-c showed nonsignificant increase. This was the pivotal evidence underlying the FDA's 1999 soy protein heart health claim of 25 g/day, but its effect estimates did not hold up. The 2006 American Heart Association science advisory listed in the references below stated that earlier research indicating soy protein has clinically important favorable effects compared with other proteins had not been confirmed. It put the average LDL reduction from 50 g/day of soy protein at approximately 3%, described that as very small relative to the large amount of soy protein tested, and reported that the average effect of isoflavones on LDL and other lipid risk factors was nil.
Acute muscle protein synthesis study using stable isotope tracers (Tang, Moore, Kujbida, Tarnopolsky, J Appl Physiol 107(3):987-992). This study is not among the references listed on this page, so treat it as uncited here.
3 groups of 6 healthy young men. Each group performed unilateral leg resistance exercise then consumed 10 g essential amino acids equivalent as whey hydrolysate, micellar casein, or soy protein isolate.
Mixed muscle protein synthesis at rest: whey 0.091 ± 0.015 vs soy 0.078 ± 0.014 vs casein 0.047 ± 0.008 %/h. Soy intermediate between whey and casein in acute MPS response. After resistance exercise, MPS was greater after whey or soy than casein. Established whey's acute superiority, but established soy as a viable option that outperformed casein.
Cumulative pooled analysis of FDA-identified soy protein studies (Blanco Mejia, Messina, Li, Viguiliouk, Chiavaroli, Khan, Srichaikul, Mirrahimi, Sievenpiper, Kris-Etherton, J Nutr 149(6):968-981).
46 studies identified by FDA for its heart health claim review, 43 of which provided data usable for pooling, examining soy protein effects on circulating LDL and total cholesterol.
Pooled effect: at a median dose of 25 g/day over a median 6 weeks, soy protein lowered LDL cholesterol by 4.76 mg/dL. Total cholesterol also decreased. The authors concluded that soy protein significantly reduced LDL cholesterol by approximately 3 to 4 percent in adults, far below the 1995 estimate. The analysis does not support a larger real-world figure.